ABIO

ARCA biopharma, Inc. Press Releases

$0.958
*  
0.0382
4.15%
Get ABIO Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading ABIO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ABIO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Arca biopharma Announces Activation of First Canadian Genetic-AF Clinical Trial Site
12/11/2014 8:30:00 AM - Business Wire
▼-7.88 % Price Change since this news event. The Volume Ratio is 4.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARCA biopharma Receives FDA Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola
12/10/2014 8:30:00 AM - Business Wire
▲19.75 % Price Change since this news event. The Volume Ratio is 4.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARCA biopharma Announces Management Transitions
12/1/2014 5:00:00 PM - Business Wire
▲19.75 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day